In the T lymphocytes of SARS-CoV-2-infected women with pneumonia, the DCA–VPA treatment changed the expression of 11 genes: it increased the expression of IL11, IL1A, IL1B, IL23A, IL24, CCL20, CXCL2, CXCL8, BMP6, and NODAL, and decreased the expression of CSF3. Here, BMP6 is linked to susceptibility to pneumonia measurement.